<unk> (inhalation) is an antibiotic that is FDA approved for the treatment of is an antibacterial aminoglycoside indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa.   Common adverse reactions include dysphonia, wheezing, epistaxis, bronchitis, tonsillitis, diarrhea, and eosinophilia.
Tobramycin 
Meropenem
Teicoplanin
Moxifloxacin 
Telithromycin
Linezolid
Clindamycin hydrochloride 
Ramoplanin